SONOMA PHARMACEUTICALS, INC. Repayments of Other Short-term Debt
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Repayments of Other Short-term Debt of $82.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherShortTermDebt · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for the quarter ending 2026-06-30 was $82.00K, a 1.23% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for the quarter ending 2026-03-31 was $51.00K, a 37.04% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for the quarter ending 2025-12-31 was $56.00K, a 31.71% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for the quarter ending 2025-09-30 was $83.00K, a 31.97% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for fiscal 2026 was $271.00K, a 32.92% decline from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for fiscal 2025 was $404.00K, a 16.01% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for fiscal 2024 was $481.00K, a 37.86% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. repayments of other short-term debt for fiscal 2023 was $774.00K.
| Period end | Repayments of Other Short-term Debt 3 month | Repayments of Other Short-term Debt 6 month | Repayments of Other Short-term Debt 9 month | Repayments of Other Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $82.00K 10-Q · filed 2026-08-06 | $133.00K derived: sum of 2 quarters · filed 2026-08-06 | $189.00K derived: sum of 3 quarters · filed 2026-08-06 | $272.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $107.00K derived: sum of 2 quarters · filed 2026-06-16 | $190.00K derived: sum of 3 quarters · filed 2026-06-16 | $271.00K 10-K · filed 2026-06-16 |
| 2025-12-31 | $56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $139.00K derived: sum of 2 quarters · filed 2026-02-10 | $220.00K 10-Q · filed 2026-02-10 | $301.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $164.00K 10-Q · filed 2025-11-04 | $245.00K derived: sum of 3 quarters · filed 2026-08-06 | $327.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $81.00K 10-Q · filed 2026-08-06 | $162.00K derived: sum of 2 quarters · filed 2026-08-06 | $244.00K derived: sum of 3 quarters · filed 2026-08-06 | $366.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $163.00K derived: sum of 2 quarters · filed 2026-06-16 | $285.00K derived: sum of 3 quarters · filed 2026-06-16 | $404.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $204.00K derived: sum of 2 quarters · filed 2026-02-10 | $323.00K 10-Q · filed 2026-02-10 | $417.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $241.00K 10-Q · filed 2025-11-04 | $335.00K derived: sum of 3 quarters · filed 2025-11-04 | $463.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $119.00K 10-Q · filed 2025-08-07 | $213.00K derived: sum of 2 quarters · filed 2025-08-07 | $341.00K derived: sum of 3 quarters · filed 2025-08-07 | $470.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $222.00K derived: sum of 2 quarters · filed 2025-06-17 | $351.00K derived: sum of 3 quarters · filed 2025-06-17 | $481.00K 10-K · filed 2025-06-17 |
| 2023-12-31 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | $257.00K derived: sum of 2 quarters · filed 2025-02-05 | $387.00K 10-Q · filed 2025-02-05 | $487.00K derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $259.00K 10-Q · filed 2024-11-07 | $359.00K derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $130.00K 10-Q · filed 2024-08-08 | $230.00K derived: sum of 2 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $774.00K 10-K · filed 2024-06-17 | ||
| 2022-12-31 | $674.00K 10-Q · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |